Endocrine Today
@EndocrineToday
Followers
15K
Following
9K
Media
1K
Statuses
23K
The content you need, when you need it.
Thorofare, NJ
Joined March 2009
Yesterday, the Trump administration struck deals with @EliLillyandCo & @novonordiskus to reduce U.S. GLP-1 prices for #obesity. The drugs will be offered at a discount for self-paying patients & those on Medicare/Medicaid. Read more on @GoHealio
healio.com
Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available obesity drugs in the U.S..
0
0
0
💪Adults with #obesity who lost 30% or more body weight with CagriSema had more soft lean tissue than fat mass at the conclusion of the REDEFINE 1 trial. Find out other benefits the drug may provide in this @ObesityWeek news👇 @SubodhVermaMD @ObseitySociety #OW2025 @PBRCNews
0
0
1
💉 Weight loss at 48 weeks with #eloralintide in a phase 2 trial ⚫ 9.5% with 1 mg ⚫ 12.4% with 3 mg ⚫ 17.6% with 6 mg ⚫ 20.1% with 9 mg @ObesityWeek @ObesitySociety @OMASocial @GoHealio #OW2025
https://t.co/E8B0v8LGpF
healio.com
ATLANTA — An investigational once-weekly amylin receptor agonist conferred substantial weight loss across six different dosing regimens for adults with overweight or obesity, researchers reported in...
0
0
2
🗣️ “Not only am I changing the weight of the patient sitting in front of me, but more importantly, I’m changing their overall health.” - Dr. Deborah Horn #orforglipron @ObesityWeek @ObesitySociety @PBRCnews #OW2025 @McGovernMed
https://t.co/jcYkorO9v0
healio.com
ATLANTA — A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic parameters for adults with obesity and type 2 diabetes, according to...
0
0
2
PROBABLY THIS IS THE MOST UNDERVALUED COMPANY ON NASDAQ — ACCORDING TO WARREN BUFFETT-STYLE ANALYSIS When Warren Buffett said, “Price is what you pay, value is what you get,” he was describing companies exactly like NextNRG Inc ($NXXT). It’s a business producing real revenue,
2
9
99
It’s the final day of #OW2025 and just look at how many doctors participated in the coloring wall in the lobby! 🌈 Just because the meeting is ending doesn’t mean our news stops! Keep checking out our profile for updates from the meeting✍️ @ObesityWeek @GoHealio
0
0
4
President Donald Trump announced deals with @EliLillyandCo and @novonordiskus to reduce prices of GLP-1s in the U.S., which could increase access for patients with #obesity. Read more on @GoHealio
https://t.co/wK7EbZ6UFQ
healio.com
Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available obesity drugs in the U.S..
0
3
3
💉The investigational #obesity drug CagriSema could offer benefits beyond weight loss. Data from 2 @ObesityWeek talks showed the drug lowered BP and improved physical function in a phase 3 trial. @SubodhVermaMD @ObseitySociety #OW2025 @PBRCNews
https://t.co/hvhLpm9Vd8
healio.com
ATLANTA — Once-weekly combined cagrilintide 2.4 mg and semaglutide 2.4 mg were tied to reductions in blood pressure and improvements in physical function among adults with obesity, according to data...
0
2
7
🚨 A once-weekly amylin receptor agonist conferred weight loss of up to 20.1% at 48 weeks for adults with #obesity, according to data presented at @ObesityWeek and published in @TheLancet. @ObesitySociety @OMASocial @GoHealio #OW2025
https://t.co/E8B0v8Mefd
healio.com
ATLANTA — An investigational once-weekly amylin receptor agonist conferred substantial weight loss across six different dosing regimens for adults with overweight or obesity, researchers reported in...
0
1
3
Really neat timeline near the entrance to the @ObesityWeek exhibit hall looking at #obesity research over the past 40 years! @ObesitySociety #OW2025
0
0
4
Federal investigators are taking a closer look at the Black Lives Matter Global Network Foundation’s finances. What could this probe mean for transparency, accountability, and the broader nonprofit sector?
19
30
194
🔍 Want a go-to reference for every approved biosimilar in the U.S.? We've compiled the full list, even those not yet launched. 📘 Access it now in Biosimilars: A Healio® Guide for Clinicians: https://t.co/fOkg2SYRm3
#Biosimilars #FDAApproved #DrugList
0
0
0
Other tools slow you down. Drug Lookup is built for the way clinicians work, fast, simple, reliable. Try it now: https://t.co/iCWDJISUXT #Physicians #MedEd
0
0
0
Day 3 live from Atlanta at #OW2025! Check out our profile for some highlights from the last two days of the meeting and keep your eyes peeled for what’s coming today! 👀 @ObesityWeek @GoHealio
0
0
2
🎤 “Not only am I changing the weight of the patient sitting in front of me, but more importantly, I’m changing their overall health.” Dr. Deborah Horn discussed a wide range of cardiometabolic benefits associated with orforglipron at @ObesityWeek. https://t.co/jcYkorO9v0
healio.com
ATLANTA — A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic parameters for adults with obesity and type 2 diabetes, according to...
0
0
1
🚨 At @ObesityWeek, researchers presented the first detailed look at results from the ATTAIN-2 phase 3 trial, which showed an oral #GLP1 can lower body weight and HbA1c for adults with #obesity and type 2 #diabetes. Read the full story ⬇️ https://t.co/jcYkorO9v0
#OW2025
healio.com
ATLANTA — A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic parameters for adults with obesity and type 2 diabetes, according to...
0
0
1
As always, Healio takes time out of our #OW2025 coverage to meet and greet the doggies available for adoption in the exhibit hall! These pups are open to their new homes, so if you want a new furry friend, stop by!
0
0
0
A stock-pumping White House unable, to mask such a market unstable, now no chance in hiding, toward panic we’re sliding, this Golden Age story pure fable.
1
0
19
Getting seated in the auditorium for the Key Lecturer talk with @ArianaMChao 👏 Is lifestyle change a thing of the past now that effective #obesity medications have become so widespread? #OW2025 @ObesityWeek
0
0
3
Dr. Daniel Bessesen of University of Colorado kicks off a panel discussion on #obesity as a chronic disease at @ObesityWeek. @ObesitySociety #OW2025
0
1
9
🎤 Dr. Marc-Andre Cornier, president of the @ObesitySociety, discusses this year’s theme of @ObesityWeek: “#Obesity is a serious chronic disease.” #OW2025
0
0
0
Your standards should make people uncomfortable. If everyone is comfortable with your expectations, they’re too low. High standards create friction. Embrace the friction. It filters out the wrong people and attracts the right ones.
0
0
52